Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer. [electronic resource]
Producer: 20140124Description: 549-56 p. digitalISSN:- 1873-2496
- Aged
- Androgen Antagonists -- adverse effects
- Disease Progression
- Drug Administration Schedule
- Humans
- Kaplan-Meier Estimate
- Male
- Nausea -- chemically induced
- Neoplasm Metastasis
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Quality of Life
- Risk Factors
- Testosterone -- blood
- Time Factors
- Treatment Outcome
- Vision Disorders -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.